Holder snapshot 6 signals
Share change
-89,651
SEC-reported price per share
$12.96
Number of holders
40
Value change
-$1,147,208
Number of buys
22
Number of sells
15
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
42,655,924

Security key

004890109

Report period

Q2 2023

Institutions

40

Top holders

10

Ownership snapshot

Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 11%
PERCEPTIVE ADVISORS LLC 7.1%
Sands Capital Alternatives, LLC 3.9%
CITADEL ADVISORS LLC 3.8%
WELLINGTON MANAGEMENT GROUP LLP 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
11%
$61,045,347
4,810,508 shares
31 Mar 2023
PERCEPTIVE ADVISORS LLC
13F
Company
13F
7.1%
$38,169,718
3,007,858 shares
31 Mar 2023
Sands Capital Alternatives, LLC
13F
Company
13F
3.9%
$20,971,557
1,652,605 shares
31 Mar 2023
CITADEL ADVISORS LLC
13F
Company
13F
3.8%
$20,148,346
1,641,022 shares
31 Mar 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
2.1%
$11,137,595
888,130 shares
31 Mar 2023
FEDERATED HERMES, INC.
13F
Company
13F
1.4%
$7,786,901
613,625 shares
31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
40
Shares
15,126,531
Rows available
40
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
39
Q2 2023 holders
40
Holder diff
1
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .